Recovery Kinetics After Different Sprint Training Protocols (STRecovery)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-01

Study Completion Date

2021-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Speed is one of the most important physical capacities for many sports, especially those that include speed and power as a major element, and plays a major role on performance. Running speed improvement is one of the most basic components of a sprint and power athlete's training program. One of the most commonly used strategies to improve the initial acceleration phase, is resisted sprint training. Sprinting is performed through the stretch-shortening cycle and highly includes the component of eccentric muscle contraction, which can lead to exercise induced muscle damage (EIMD). This phenomenon includes symptoms such as plasma CK elevation, delayed onset of muscle soreness, reduction in force production and a reduction in agility and speed. However, despite the fact that sprint training can cause EIMD symptoms and a performance reduction the following days, research evidence on the recovery kinetics after sprint training are scarce. However, such information is critical for coaches and athletes, in order to effectively design a training program and incorporate the training components in the training microcycle, to avoid injuries and maximize performance. The aim of the present study is to examine the recovery kinetics of EIMD indices, muscle performance and neuromuscular fatigue, after different sprint training protocols.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Recovery Following Acute Endurance Training

NCT06043492

High Intensity Interval Training Continuous Running Control Condition

COMPLETED NA

Post-activation Potentiation and Sprinting Performance

NCT06619899

Sprint Performance

COMPLETED NA

Recovery of Performance, Muscle Damage and Neuromuscular Fatigue Following Muscle Power Training

NCT03936595

Power Training Exercise Protocols

TERMINATED NA

Recovery Kinetics Following a Soccer Training in Middle-aged Males

NCT06260215

Skeletal Muscle Damage

COMPLETED NA

Recovery Kinetics After Speed-Εndurance Maintenance Training

NCT04748315

Muscle Damage

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Speed is one of the most important physical capacities for many sports, especially those that include speed and power as a major element, and plays a major role on performance. Thus, running speed improvement consists one of the most basic aims of a sprinter's and a power athlete's training program. One of the most commonly used strategies to improve the initial acceleration phase, is resisted sprint training. Evidence suggests that resisted sprint training is more effective in improving acceleration compared to sprint training without additional load. Sprinting is performed through the stretch-shortening cycle, where the pre-activated muscle is first stretched (eccentric action) and then followed by the shortening (concentric) action. Thus, sprint training highly includes the component of eccentric contraction. However, eccentric muscle action, especially when unaccustomed, can lead to exercise-induced muscle damage (EIMD). Although concentric and isometric exercise may also lead to muscle injury, the amount of damage after eccentric muscle contractions is greater. EIMD, amongst others, is accompanied by increased levels of creatine kinase (CK) into the circulation, increased delayed onset of muscle soreness (DOMS), reduction of force production, reduction of agility and speed. Nevertheless, despite the fact that sprint training comprises eccentric muscle actions and consequently can lead to muscle injury and muscle performance reduction during the following days, the recovery kinetics after acute sprint training have not been adequately studied. However, such information is critical for both coaches and athletes to effectively design the training microcycles and incorporate the training components, as well as to reduce injury risk.

The aim of the present study is to examine the recovery kinetics of EIMD indices, muscle performance and neuromuscular fatigue, after different sprint training protocols.

According to a preliminary power analysis (a probability error of 0.05, and a statistical power of 80%), a sample size of 8 - 10 subjects per group was considered appropriate in order to detect statistically meaningful changes between groups.

The study will be performed in a randomized, cross over, repeated measures design. During the first 1st and 2nd visit, all participants will sign an informed consent form after they will be informed about all the benefits and risks of the study and they will fill in and sign a medical history questionnaire. Fasting blood samples will be collected in order to estimate muscle damage concentration markers. Participants will be instructed by a dietitian how to record a 7-days diet recalls to ensure that they do not consume to greater extent nutrients that may affect EIMD and fatigue (e.g. antioxidants, amino acids, etc.) and to ensure that the energy intake during the trials will be the same. Assessment of body mass and body height, body composition, and aerobic capacity (VO2max), will be performed. Running speed of 10 m, 20 m and 30 m sprint will be measured on a track and field stadium. Squat jump and countermovement jump will be performed on a force platform to assess jump height, ground reaction force, peak and mean power, vertical stiffness and peak rate of force development; at the same time, peak and mean normalized EMG during the concentric phase of the squat jump, and during eccentric and concentric phases of the counter movement jump, for the vastus lateralis, biceps femoris, gastrocnemius, and gluteus maximum muscles will be assessed. The peak concentric, eccentric and isometric isokinetic torque of the knee flexors and extensors, in both limbs will be evaluated on an isokinetic dynamometer at 60°/sec. Maximal voluntary isometric contraction (MVIC) of the knee extensors at 65o in both limbs, as well as the fatigue rate during MVIC through the percent drop of peak torque between the first and the last three seconds of a 10-sec MVIC.

During the 3rd visit, participants will be randomly assigned into, and perform one of the four different conditions of the study design: a) unresisted sprint training, b) resisted sprint training with a load of 10% of body weight (BW), c) resisted sprint training with a load of 20% of BW d) control condition. Prior to each experimental protocol, assessment of DOMS in the knee flexors (KF) and extensors (KE) of both limbs, as well as blood lactate assessment will be performed. Additionally, DOMS of KF and KE, running speed at 10 m, 20 m and 30 m sprint, peak concentric, eccentric and isometric isokinetic torque, squat and countermovement jump height, as well as ground reaction force, peak and mean power, vertical stiffness and peak rate of force development during squat and countermovement jump, alongside with peak and mean normalized electromyography (EMG) during the concentric phase of the squat jump, and during eccentric and concentric phases of the counter movement jump, for the vastus lateralis, biceps femoris, gastrocnemius, and tibialis anterior muscles will be assessed immediately after, 24h, 48h and 72h after the end of the trial. MVIC of the knee extensors of both limbs, as well as the fatigue rate during MVIC will also be assessed at 1h, 2h and 3h, as well as 24h, 48h, and 72h after the end of the trial. Blood lactate will also be assessed at 4 min, while creatine kinase at 24h, 48h, and 72h after the end of the trial. The exact above procedures will be repeated by the participants during the remaining three experimental trials (7th - 10th, 11th - 13th, and 14th - 16th visits).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sprint Training

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Unresisted sprint training

Participants will perform an acute training bout of unresisted sprints.

Group Type EXPERIMENTAL

Unresisted sprint training

Intervention Type OTHER

Particiapants will perform:

2 sets of 3 x 20m sprint

1 set of 3 x 30m sprint

Resisted sprint training with load equal to 10% of body weight

Participants will perform an acute training bout of resisted sprints with load equal to 10% of body weight.

Group Type EXPERIMENTAL

Resisted sprint training with load equal to 10% of body weight

Intervention Type OTHER

Particiapants will perform:

2 sets of 3 x 20m sprint

1 set of 3 x 30m sprint

Resisted sprint training with load equal to 20% of body weight

Participants will perform an acute training bout of resisted sprints with load equal to 20% of body weight.

Group Type EXPERIMENTAL

Resisted sprint training with load equal to 20% of body weight

Intervention Type OTHER

Particiapants will perform:

2 sets of 3 x 20m sprint

1 set of 3 x 30m sprint

Control trial

Participants will perform no training protocol. They will only perform all the measurements.

Group Type EXPERIMENTAL

Control trial

Intervention Type OTHER

Participants will not perform any sprint training protocol

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Unresisted sprint training

Particiapants will perform:

2 sets of 3 x 20m sprint

1 set of 3 x 30m sprint

Intervention Type OTHER

Resisted sprint training with load equal to 10% of body weight

Particiapants will perform:

2 sets of 3 x 20m sprint

1 set of 3 x 30m sprint

Intervention Type OTHER

Resisted sprint training with load equal to 20% of body weight

Particiapants will perform:

2 sets of 3 x 20m sprint

1 set of 3 x 30m sprint

Intervention Type OTHER

Control trial

Participants will not perform any sprint training protocol

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Srinters or athletes that comprise sprint training in their training programs
* Absense of musculoskeletal injuries (≥ 6 months)
* Abstence from use of ergogenic supplements or other drugs (≥ 1 month)
* Abstence from participation at exercise with eccentric component (≥ 3 days)
* Abstence from alcohol and energy drings consumption before each experimental trial

Exclusion Criteria

* Musculoskeletal injuries (≤ 6 months)
* Use of ergogenic supplements or other drugs (≤ 1 month)
* Participation at exercise with eccentric component (≤ 3 days)
* Alcohol and energy drings consumption before the experimental trials

Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes